Amphista Theraperutics’ Collaboration and License Agreement With Merck Healthcare

Gowling WLG has advised Amphista Theraperutics on the deal.The deal concerns an agreement with Merck Healthcare to collaborate in developing novel protein degrading therapeutics in indications…

This content is for Standard 1 Year members only.
Login Join Now
Giulia Di Palma

Author: Giulia Di Palma

This content is for Standard 1 Year members only.
Login Join Now